Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Pediatric Oncology
Would you offer adjuvant RT for a pediatric patient with a grade 2, myxopapillary spinal ependymoma s/p GTR?
Related Questions
How do you counsel cancer patients when they ask if they should avoid sugar?
What is your approach to cancer patients who inquire about alternative or complementary treatments?
What are magic mouthwash alternatives that you would recommend?
How would you manage a patient with radiation pneumonitis who remains symptomatic on steroids?
Should improving imaging chest standards for staging impact the radiographic response criteria for lung metastases in Wilms?
Which patients with relapsed/refractory NHL are appropriate for pre-CAR-T bridging radiation therapy?
Should all patients with a remote history of immunotherapy, chemotherapy and/or radiation therapy have a baseline TTE regardless of ASCVD risk?
What are the key local therapy considerations for patients with malignant pleural effusion, bulky pleural disease, lung metastases and chest wall/diaphragm primary in a patient with Rhabdomyosarcoma or Ewing Sarcoma?
What special considerations do you take when treating cancer patients with severe intellectual disabilities?
In a patients with bilateral Wilms' tumor (treated as per AREN0534) with favorable features (>90% response to VAD, no anaplasia), what histopathologic criteria should be used to define a positive margin requiring focal RT to a partial nephrectomy bed?
